TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 30 filers reported holding TALIS BIOMEDICAL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $751 | -2.0% | 1,564 | 0.0% | 0.00% | – |
| Q1 2023 | $766 | – | 1,564 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,564 | -21.8% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -77.8% | 2,000 | -7.0% | 0.00% | – |
| Q4 2021 | $9,000 | -30.8% | 2,150 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 2,150 | +87.0% | 0.00% | – |
| Q2 2021 | $13,000 | -13.3% | 1,150 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | – | 1,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,073,176 | 0.05% |
| WELLS FARGO & COMPANY/MN | 174 | $84 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,373 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 140,530 | $67,454 | 0.00% |
| STATE STREET CORP | 47,436 | $22,769 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 91,463 | $43,902 | 0.00% |
| DEUTSCHE BANK AG\ | 45,294 | $21,741 | 0.00% |
| MORGAN STANLEY | 61,857 | $29,691 | 0.00% |
| BlackRock Inc. | 76,307 | $36,628 | 0.00% |